Hello from a seasonably cold, but not too snowy Boston! I can hardly believe we are entering the back half of February and will soon be headed into March and to the NACHC P&I Conference in Washington DC. As we exit UDS Season, I wanted to take a...
Most clinical quality measures have some sort of age criteria. Consider NQF 0418, the depression screening and follow-up measure. The basic description is:
Percentage of patients aged 12 years and older screened for depression on the date of the...
Back in 2016, Azara published two blog posts on the difference between the two ways diagnoses are added to a patient’s chart (problems and assessments) when to use them, and the impact this has on clinical quality measures. As DRVS has evolved to...
As 2018 comes to a close, I wanted to take a moment to reflect on the past year. What a special year it has been! From a geographical standpoint, the Azara team has visited DRVS users, prospects and partners across nearly every state in the Union,...
In August, the U.S. Department of Health and Human Services (HHS) announced $125 million in Quality Improvement grant awards awarded to 1,352 community health centers. Funded by the Health Resources and Services Administration (HRSA), health centers...
Over the last 4 years, we’ve seen the performance on Tobacco Use: Screening and Cessation Measure (CMS 138v6 / NQF 0028) rates increase, but recently you may have noticed a drop in your performance and wondered ‘what’s happening?’ Did something...
